¿Quiénes somos?

About us

Ascires is Spain’s leading biomedical group in Genetics, Diagnostic Imaging and Nuclear Medicine.

We treat more than

500,000 patients

per year

We reinvest

20% of our profits

into R+D+i

We have

over 50 years

of experience

We dedicate

65,000 hours

per year to research

About Ascires Biomedical Group

With a team of over 700 professionals, Ascires focuses its activity on precision diagnosis and individualised treatment. By volume of annual patients treated and medical technology, we are Spain’s leading biomedical group in Genetics, Diagnostic Imaging and Nuclear Medicine, as well as a benchmark in Radiation Oncology. We treat more than 500,000 patients a year in public and private hospitals where the group provides its Diagnostic Imaging and Genetics services and in our network of Ascires biomedical clinics.

With over 50 years of experience, Ascires reinvests 20% of its profits in R+D+i and dedicates an average of 65,000 hours per year to research. An investment effort that allows us to incorporate the latest advances in biomedical technology, both in Genomics and Diagnostic Imaging and Radiotherapy.

Ascires Biomedical Group is made up of three pioneering teams in Spain in their respective fields: the first massive genetic sequencing for clinical diagnosis (2009), the first magnetic resonance imaging scan (1983) and the first image-guided radiation therapy (2005). Our vocation is always aimed at making the latest medical advances accessible to the patient.

The biomedical group is currently applying Artificial Intelligence (AI), big data and Deep Learning to all its lines of activity with the aim of maximising the precision of diagnoses and treatments.

Our Story

Genetic PCR test for the diagnosis of Covid-19

Introduction to the Valencian Community of the first MR-guided Neuro-HIFU treatment.

AsciresTools: Artificial Intelligence applied to medical imaging to maximize diagnostic accuracy.

ERESA optimizes treatment in radiotherapy oncology using Bolus 3D application.
Birth of Ascires.

ERESA-CETIR introduces HIFU technology for essential tremor.

Sistemas Genómicos obtains CLIA-USA certification. It also registers the first product with CE marking (next-generation sequencing kits).

ERESA makes the first High-Definition CT machine with spectral imaging in Spain.

Sistemas Genómicos is the first company in Spain to offer genomic diagnostics.

Merger of CETIR and ERESA

Sistemas Genómicos is a pioneer in the use of massive sequencing for diagnosis.

Sistemas Genómicos was a pioneer by participating in the largest genome sequencing project conducted in Europe.

Sistemas Genómicos was part of the international consortium of sequencing of a Eucariota, being the cover of Nature.

ERESA offers the first service in Spain of Image Guided Radiotherapy (IGRT) to improve the accuracy of radiation in tumours.

ERESA is a pioneer in Europe in the use of Intensity-Modulated Radiotherapy (IMRT) for the treatment of cancer.

 

 

ERESA incorporates the first Valencian Community Digital Linear Accelerator for Radiotherapy.
CETIR obtains ISO certification for all Care Services.

Birth of Sistemas Genómicos in Valencia.

CETIR creates the first Central Radiopharmacy Unit in Spain.

CETIR creates the Neuroimaging Research Unit.

CETIR was a pioneer with the first Magnetic Resonance Imaging machine in Spain.

Birth of the Radiological Group, the forerunner of ERESA in Valencia.

Clínica ERESA was one of the first to install a CT machine in Spain.

Birth of CETIR in Catalonia.

ERESA contributes in the first open-heart operation on a newborn using a 3D printed replica as a guide

Big Data applies to Precision Diagnostics.

Birth of the Fundación QUAES, promoted by CETIR, ERESA and Sistemas Genómicos.

ASCIRES, pioneers in the incorporation of PET/MRI in Spain.